Evidence-based clinical review Gene Therapy for Spinal Muscular Atrophy in 2026: Lessons from the Frontlines Estimated reading time: 15 minutes Abstract Background Gene transfer has fundamentally changed the natural history of 5q spinal muscular atrophy
